These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24998655)
1. [Down-regulation of Notch1 by small interfering RNA enhances chemosensitivity to gemcitabine in pancreatic cancer cells through activating apoptosis activity]. Du X; Wang YH; Wang ZQ; Cheng Z; Li Y; Hu JK; Chen ZX; Zhou ZG Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):313-8. PubMed ID: 24998655 [TBL] [Abstract][Full Text] [Related]
2. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression. Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226 [TBL] [Abstract][Full Text] [Related]
3. hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3. Tan J; Zhou X; Zhu H Exp Clin Transplant; 2012 Aug; 10(4):386-93. PubMed ID: 22757972 [TBL] [Abstract][Full Text] [Related]
4. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA]. Kong R; Sun B; Wang SJ; Pan SH; Wang G; Chen H; Xue DB; Jiang HC Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):128-33. PubMed ID: 20302733 [TBL] [Abstract][Full Text] [Related]
5. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. Yao J; Qian C Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816 [TBL] [Abstract][Full Text] [Related]
7. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920 [TBL] [Abstract][Full Text] [Related]
8. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer. Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Wang TX; You L; Shu H Arch Med Res; 2014 Jan; 45(1):15-20. PubMed ID: 24316112 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312 [TBL] [Abstract][Full Text] [Related]
10. Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer. Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Cui QC; Shi J; Wang TX; You L; Shu H World J Surg; 2013 Jul; 37(7):1688-94. PubMed ID: 23568245 [TBL] [Abstract][Full Text] [Related]
11. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. Jiang C; Yi XP; Shen H; Li YX World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919 [TBL] [Abstract][Full Text] [Related]
12. Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA. Li Y; Gu WJ; Liu HL Dig Dis Sci; 2012 Aug; 57(8):2072-8. PubMed ID: 22573342 [TBL] [Abstract][Full Text] [Related]
13. siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway. Liu D; Zhang Y; Dang C; Ma Q; Lee W; Chen W Oncol Rep; 2007 Sep; 18(3):673-7. PubMed ID: 17671718 [TBL] [Abstract][Full Text] [Related]
14. Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling. Jin X; Wu Y Anat Rec (Hoboken); 2014 May; 297(5):802-9. PubMed ID: 24619961 [TBL] [Abstract][Full Text] [Related]
15. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody. Huang ZQ; Buchsbaum DJ; Raisch KP; Bonner JA; Bland KI; Vickers SM J Surg Res; 2003 May; 111(2):274-83. PubMed ID: 12850474 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236 [TBL] [Abstract][Full Text] [Related]
17. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer. Wang C; Huang H Biochem Biophys Res Commun; 2021 Nov; 579():181-187. PubMed ID: 34624736 [TBL] [Abstract][Full Text] [Related]
18. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594 [TBL] [Abstract][Full Text] [Related]
19. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro. Xiong GS; Sun HL; Wu SM; Mo JZ J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735 [TBL] [Abstract][Full Text] [Related]
20. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity. Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]